Screener
Veracyte VCYT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Financing activities | ||
| Payment of taxes on vested restricted stock units | (9,364) | (9,451) |
| Proceeds from the exercise of common stock options and employee stock purchases | 2,735 | 2,967 |
| Net cash used in financing activities | (6,629) | (6,484) |
| Decrease in cash, cash equivalents and restricted cash | (99,375) | (52,940) |
| Effect of foreign currency on cash, cash equivalents and restricted cash | (58) | 74 |
| Net decrease in cash, cash equivalents and restricted cash | (99,433) | (52,866) |
| Cash, cash equivalents and restricted cash at beginning of period | 364,226 | 240,631 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's financing cash flow?
- Veracyte (VCYT) reported financing cash flow of -$6.63M in Q1 2026.
- How has Veracyte's financing cash flow changed year-over-year?
- Veracyte's financing cash flow decreased by 2.2% year-over-year, from -$6.48M to -$6.63M.
- What is the long-term trend for Veracyte's financing cash flow?
- Over 2 years (2021 to 2023), Veracyte's financing cash flow has grown at a -93.1% compound annual growth rate (CAGR), from $596.32M to $2.84M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Veracyte's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude